What is the half-life of Abaloparatide?

Abaloparatide has an approximate elimination half-life of 1 h.

How long does Abaloparatide stay in your system?

Roughly 97% of a dose has cleared after five half-lives — about ~5 h for Abaloparatide. That is the window that matters for washouts, bloodwork and surgery.

How is Abaloparatide taken?

Abaloparatide is typically administered by the subcutaneous route. Prescription medicine in the US. The prescriber sets the dose and schedule; the FDA label is cited on this page.

What are the risks of Abaloparatide?

Osteosarcoma risk: abaloparatide caused a dose-dependent increase in osteosarcoma in rats (label warning) Orthostatic hypotension may occur, typically in the hours after an injection Can raise blood calcium (hypercalcemia) and urine calcium, with a risk of kidney stones Hypersensitivity reactions, including anaphylaxis, have been reported

Abaloparatide

Tymlos PTHrP(1-34)

A synthetic 34-amino-acid analog of parathyroid hormone-related peptide, PTHrP(1-34). Approved in the US for osteoporosis at high risk of fracture.

Half-life: 1 h
Out of system: ~5 h
Route: Subcutaneous
Level: —

Class (Parathyroid hormone-related peptide [PTHrP(1-34)] analog), half-life and route from the FDA label: Tymlos (abaloparatide) injection (U.S. National Library of Medicine, DailyMed), checked 2026-09-26.

What Abaloparatide is used for

Treatment of postmenopausal women with osteoporosis at high risk for fracture (FDA label)
Treatment to increase bone density in men with osteoporosis at high risk for fracture (FDA label)

How it's typically used

Prescription medicine in the US. The prescriber sets the dose and schedule; the FDA label is cited on this page.

What to watch for

Osteosarcoma risk: abaloparatide caused a dose-dependent increase in osteosarcoma in rats (label warning)
Orthostatic hypotension may occur, typically in the hours after an injection
Can raise blood calcium (hypercalcemia) and urine calcium, with a risk of kidney stones
Hypersensitivity reactions, including anaphylaxis, have been reported

Common questions

What is the half-life of Abaloparatide?: Abaloparatide has an approximate elimination half-life of 1 h.
How long does Abaloparatide stay in your system?: Roughly 97% of a dose has cleared after five half-lives — about ~5 h for Abaloparatide. That is the window that matters for washouts, bloodwork and surgery.
How is Abaloparatide taken?: Abaloparatide is typically administered by the subcutaneous route. Prescription medicine in the US. The prescriber sets the dose and schedule; the FDA label is cited on this page.
What are the risks of Abaloparatide?: Osteosarcoma risk: abaloparatide caused a dose-dependent increase in osteosarcoma in rats (label warning) Orthostatic hypotension may occur, typically in the hours after an injection Can raise blood calcium (hypercalcemia) and urine calcium, with a risk of kidney stones Hypersensitivity reactions, including anaphylaxis, have been reported

About Other research compounds

What they are: Nootropics, metabolic agents, and research compounds that don't fit the other classes.
How they're run: Route and schedule vary widely — check the individual entry.
What to watch: This is the least-characterised corner of the atlas. Read the full guide, and treat anything without published human data as exactly that.

Other other research compounds

Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.